Dullaart, Robin P.F.

TMAO is Associated with Mortality: Impact of Modestly Impaired Renal Function

Gruppen, E. G., Garcia, E., Connelly, M. A., Jeyarajah, E. J., Otvos, J. D., Bakker, S. J. L., & Dullaart, R. P. F. (2017) · Scientific Reports

Chronic Kidney Disease and DiabetesGut microbiota and health

Cited by 146

Separating the Mechanism-Based and Off-Target Actions of Cholesteryl Ester Transfer Protein Inhibitors With CETP Gene Polymorphisms

Sofat, R., Hingorani, A. D., Smeeth, L., Humphries, S. E., Talmud, P. J., Cooper, J., Shah, T., Sandhu, M. S., Ricketts, S. L., Boekholdt, S. M., et al. (2010) · Circulation

Lipoproteins and Cardiovascular HealthParaoxonase enzyme and polymorphisms

Cited by 104

Thyroid Function Within the Reference Range and the Risk of Stroke: An Individual Participant Data Analysis

Chaker, L., Baumgartner, C., den Elzen, W. P. J., Collet, T.-H., Ikram, M. A., Blum, M. R., Dehghan, A., Drechsler, C., Luben, R. N., Portegies, M. L. P., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism

Thyroid Disorders and TreatmentsAcute Ischemic Stroke Management

Cited by 92

Treatment of Amiodarone-Induced Thyrotoxicosis Type 2: A Randomized Clinical Trial

Eskes, S. A., Endert, E., Fliers, E., Geskus, R. B., Dullaart, R. P. F., Links, T. P., & Wiersinga, W. M. (2012) · The Journal of Clinical Endocrinology & Metabolism

Thyroid Disorders and TreatmentsAdrenal Hormones and Disorders

Cited by 78

Advanced glycation end products: An emerging biomarker for adverse outcome in patients with peripheral artery disease

de Vos, L. C., Lefrandt, J. D., Dullaart, R. P. F., Zeebregts, C. J., & Smit, A. J. (2016) · Atherosclerosis

Advanced Glycation End Products researchPeripheral Artery Disease Management

Cited by 77

Unenhanced CT imaging is highly sensitive to exclude pheochromocytoma: a multicenter study

Buitenwerf, E., Korteweg, T., Visser, A., Haag, C. M. S. C., Feelders, R. A., Timmers, H. J. L. M., Canu, L., Haak, H. R., Bisschop, P. H. L. T., Eekhoff, E. M. W., et al. (2018) · European Journal of Endocrinology

Adrenal and Paraganglionic TumorsNeuroendocrine Tumor Research Advances

Cited by 72

Apolipoprotein A-II influences apolipoprotein E-linked cardiovascular disease risk in women with high levels of HDL cholesterol and C-reactive protein

Corsetti, J. P., Bakker, S. J. L., Sparks, C. E., & Dullaart, R. P. F. (2012) · PLoS ONE

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 66

The optimal healthy ranges of thyroid function defined by the risk of cardiovascular disease and mortality: systematic review and individual participant data meta-analysis

Xu, Y., Derakhshan, A., Hysaj, O., Wildisen, L., Ittermann, T., Pingitore, A., Abolhassani, N., Medici, M., Kiemeney, L. A. L. M., Riksen, N. P., et al. (2023) · The Lancet Diabetes & Endocrinology

Thyroid Disorders and TreatmentsThyroid and Parathyroid Surgery

Cited by 61

Vascular risk factors, vascular disease, lipids and lipid targets in patients with familial dysbetalipoproteinemia: A European cross-sectional study

Koopal, C., Retterstøl, K., Sjouke, B., Hovingh, G. K., Ros, E., de Graaf, J., Dullaart, R. P. F., Bertolini, S., & Visseren, F. L. J. (2015) · Atherosclerosis

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 58

Optimal screening for predicting and preventing the risk of heart failure among adults with diabetes without atherosclerotic cardiovascular disease: a pooled cohort analysis

Patel, K. V., Segar, M. W., Klonoff, D. C., Khan, M. S., Usman, M. S., Lam, C. S. P., Verma, S., DeFilippis, A. P., Nasir, K., Bakker, S. J. L., et al. (2024) · Circulation

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 38

Hydrocortisone dose influences pain, depressive symptoms and perceived health in adrenal insufficiency: a randomized controlled trial

Werumeus Buning, J., Brummelman, P., Koerts, J., Dullaart, R. P. F., van den Berg, G., van der Klauw, M. M., Sluiter, W. J., Tucha, O., Wolffenbuttel, B. H. R., & van Beek, A. P. (2016) · Neuroendocrinology

Adrenal Hormones and DisordersStress Responses and Cortisol

Cited by 37

Apolipoprotein E predicts incident cardiovascular disease risk in women but not in men with concurrently high levels of high-density lipoprotein cholesterol and C-reactive protein

Corsetti, J. P., Gansevoort, R. T., Bakker, S. J. L., Navis, G., Sparks, C. E., & Dullaart, R. P. F. (2012) · Metabolism

Lipoproteins and Cardiovascular HealthParaoxonase enzyme and polymorphisms

Cited by 30

Plasma ApoE elevations are associated with NAFLD: The PREVEND Study

van den Berg, E. H., Corsetti, J. P., Bakker, S. J. L., & Dullaart, R. P. F. (2019) · PLOS ONE

Liver Disease Diagnosis and TreatmentLipid metabolism and disorders

Cited by 27

Adiposity and the development of dyslipidemia in APOE ε2 homozygous subjects: A longitudinal analysis in two population-based cohorts

Heidemann, B. E., Wolters, F. J., Kavousi, M., Gruppen, E. G., Dullaart, R. P., Marais, A. D., Visseren, F. L., & Koopal, C. (2021) · Atherosclerosis

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 21

Insulin resistance involvement in prevalence of familial dysbetalipoproteinemia in ε2ε2 subjects by Bayesian network modeling

Corsetti, J. P., Love, T. M., Sparks, C. E., Bakker, S. J. L., & Dullaart, R. P. F. (2018) · Clinical Biochemistry

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 7